Immune checkpoint inhibitor-induced colitis complicated with inflammatory intestinal obstruction: a case report and literature review

BACKGROUND: The combination therapy using anti-angiogenic drugs and immune checkpoint inhibitors (ICIs) has an excellent safety profile and manageable toxicity. However, ICI therapy may lead to a variety of autoimmune events, known as immune-related adverse events (irAEs), which some secondary compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Shunde, Zhu, Gang, Fan, Jun, Chen, Jianfei, Li, Xinkai, Peng, Yisheng, Su, Song, Fang, Cheng, Yang, Xiaoli, Li, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372204/
https://www.ncbi.nlm.nih.gov/pubmed/35966294
http://dx.doi.org/10.21037/tcr-21-2501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372204/
https://www.ncbi.nlm.nih.gov/pubmed/35966294
http://dx.doi.org/10.21037/tcr-21-2501

Ejemplares similares